Efforts to get Gilead’s experimental COVID-19 drug remdesivir to patients in badly-hit India are building after drug maker Cipla announced it had launched the drug in the country.
Sanofi is to create a European company focused on production and marketing of active pharmaceutical ingredients (API) – the essential building blocks of medicines that are causing concerns